Metabolon Logo
  • Metabolomics
    • Column 1
      • Why Metabolomics?
        • Metabolomics, Metabolites, and the Metabolome
      • Why Metabolon?
        • Coverage
        • Quantitation
        • Visualization
        • Interpretation
        • Validation
        • Machine Learning & Artificial Intelligence
    • Column 2
      • Working With Us
        • Study Design & Consulting
        • Our Technology & Knowledgebase
        • Research Standards
        • Sample Preparation & Handling
        • Sample Handling Kit
        • Reporting & Interpretation
        • Deliverables
  • Services
    • Column 1
      • Metabolon Discover
        • Global Discovery Panel
    • Column 2
      • Metabolon Target
        • Amino Acids Targeted Panel
        • Bile Acids Targeted Panel
        • Cannabinoids Targeted Panel
        • Central Carbons Targeted Panel
        • Complex Lipids Targeted Panel
        • Diabetes Research Markers Targeted Panel
        • Fatty Acids Metabolism Targeted Panel
        • Free Fatty Acids Targeted Panel
        • Impaired Glucose Tolerance Targeted Panel
        • Indoles/Uremic Toxicity Targeted Panel
    • Column 3
      • .
        • Insulin Resistance Targeted Panel
        • Lipid Mediators of Inflammation Targeted Panel
        • Metal Analysis Targeted Panel
        • Oxysterols Targeted Panel
        • Sebum Targeted Panel
        • Short Chain Fatty Acids Targeted Panel
        • Sphingolipids Targeted Panel
        • Stratum Corneum Targeted Panel
        • Tryptophan/Kynurenine Ratio Targeted Panel
        • Custom Targeted Panel
    • Column 4
      • Single Analyte Assays
        • C4 Single Analyte Assay
        • Salivary Glucose Single Analyte Assay
        • Beta Hydroxybutyrate Single Analyte Assay
        • Creatinine Single Analyte Assay
        • Custom Single Analyte Assay
      • Sample Collection
        • OMNImet GUT
  • Applications
    • Column 1
      • Markets
        • Academic
        • Agriculture
        • BioPharma
        • – BioPharma Discovery
        • – BioPharma Clinical
        • Bioprocessing
    • Column 2
      • .
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Precision Medicine
        • Veterinary & Animal Health
    • Column 3
      • Therapeutic Areas
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Inflammation
    • Column 4
      • .
        • Neuroscience
        • Oncology
        • Renal and Urological Disorders
        • Respiratory Disorders
        • Immuno-Oncology
  • Resources
    • Resource Library
    • Publications
    • Client Case Studies
    • Videos
    • Blog
    • Release Notes
    • Sample Shipment
  • Company
    • About Us
    • Leadership
    • Careers
    • Strategic Partnering
    • Press Kit
    • News
    • Events
    • Newsletter Sign Up
    • Contact Us
  • MyMetabolon
  • Contact Us
Search Results

Results for "diabetes"

LP – Diabetes Research Markers Targeted Panel

read more
Diabetes Research Markers

Diabetes Research Markers

read more
ATTD (Advanced Technologies & Treatments for Diabetes) 2023

ATTD (Advanced Technologies & Treatments for Diabetes) 2023

read more
Case Study: Metabolite Biomarkers for Type 2 Diabetes (T2D)

Case Study: Metabolite Biomarkers for Type 2 Diabetes (T2D)

read more
Case Study: Periodontal Disease and Diabetes Biomarkers

Case Study: Periodontal Disease and Diabetes Biomarkers

read more
Finding Biomarkers for Diabetes

Finding Biomarkers for Diabetes

read more
Metabolomics and Glucose Intolerance—Diving Deeper into this Diabetes Driver

Metabolomics and Glucose Intolerance—Diving Deeper into this Diabetes Driver

read more

Diabetes

read more
Case study: Gut Microbiome and Diabetes

Case study: Gut Microbiome and Diabetes

read more
Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes

Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes

read more
Metabolon technology identifies key gut microbiome-derived compound linked to insulin resistance in people with Type 2 diabetes

Metabolon technology identifies key gut microbiome-derived compound linked to insulin resistance in people with Type 2 diabetes

read more
Global Metabolomics for Diabetes Research

Global Metabolomics for Diabetes Research

read more
Metabolomics for NAFLD/NASH

Metabolomics for NAFLD/NASH

read more
Bile Acids, the Microbiome, and Human Health

Bile Acids, the Microbiome, and Human Health

read more
Metabolon’s February 2023 Metabolomics Citations

Metabolon’s February 2023 Metabolomics Citations

read more
« Older Entries
Small Molecules, Big Insights

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2023 Metabolon, Inc. All rights reserved. Privacy & Terms

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Metabolomics

Why Metabolomics?

Why Metabolon?

Working With Us

Services

Metabolon Discover

Metabolon Target

Single Analyte Assays

Applications

Markets

Therapeutic Areas

Resources

Resources

Publications

Case Studies

Videos

Blog

Sample Shipment

Metabolon
  • Metabolomics
    • Why Metabolomics?
      • Your Guide to Metabolomics
    • Why Metabolon?
      • Coverage
      • Quantitation
      • Visualization
      • Interpretation
      • Validation
      • Machine Learning & Artificial Intelligence
    • Working With Us
      • Study Design & Consulting
      • Our Technology & Knowledgebase
      • Research Standards
      • Sample Preparation & Handling
      • Sample Handling Kit
      • Reporting & Interpretation
      • Deliverables
  • Services
    • Metabolon Discover
      • Global Discovery Panel
    • Metabolon Target
      • Amino Acids Targeted Panel
      • Bile Acids Targeted Panel
      • Cannabinoids Targeted Panel
      • Central Carbons Targeted Panel
      • Complex Lipids Targeted Panel
      • Diabetes Research Markers Targeted Panel
      • Fatty Acids Metabolism Targeted Panel
      • Free Fatty Acids Targeted Panel
      • Impaired Glucose Tolerance Targeted Panel
      • Indoles/Uremic Toxicity Targeted Panel
      • Insulin Resistance Targeted Panel
      • Lipid Mediators of Inflammation Targeted Panel
      • Metal Analysis Targeted Panel
      • Oxysterols Targeted Panel
      • Sebum Targeted Panel
      • Short Chain Fatty Acids Targeted Panel
      • Sphingolipids Targeted Panel
      • Stratum Corneum Targeted Panel
      • Tryptophan/Kynurenine Ratio Targeted Panel
      • Custom Targeted Panel
    • Single Analyte Assays
      • C4 Single Analyte Assay
      • Salivary Glucose Single Analyte Assay
      • Vancomycin Single Analyte Assay
      • Beta Hydroxybutyrate Single Analyte Assay
      • Creatinine Single Analyte Assay
      • Custom Single Analyte Assay
    • Sample Collection
      • OMNImet GUT
  • Applications
    • Markets
      • Academic
      • Agriculture
      • BioPharma
      • – BioPharma Discovery
      • – BioPharma Clinical
      • Bioprocessing
      • Nutrition
      • Personal Care & Cosmetics
      • Population Health
      • Precision Medicine
      • Veterinary & Animal Health
    • Therapeutic Areas
      • Cardiovascular Disease
      • COVID-19
      • Diabetes
      • Gastrointestinal
      • Liver Disease
      • Inflammation
      • Neuroscience
      • Oncology
      • Renal and Urological Disorders
      • Respiratory Disorders
      • Immuno-Oncology
  • Resources
    • Resource Library
    • Publications
    • Client Case Studies
    • Videos
    • Blog
    • Release Notes
    • Sample Shipment
  • Company
    • About Us
    • Leadership
    • Careers
    • Strategic Partnering
    • Press Kit
    • News
    • Events
    • Contact Us
  • MyMetabolon
  • Contact Us